ProKidney Corp. (PROK)

ProKidney Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	0.08	-	-	-	-
Gross Profit	0.08	-	-	-	-
Selling, General & Admin	50.76	44.82	70.94	8.86	5.98
Research & Development	127.67	106.71	82.07	46.26	21.04
Operating Expenses	178.43	151.52	153.01	55.11	27.02
Operating Income	-178.35	-151.52	-153.01	-55.11	-27.02
Interest Expense	-0.01	-0.01	-0.22	-	-
Interest & Investment Income	19.75	22.08	5.98	0	0.04
EBT Excluding Unusual Items	-158.61	-129.45	-147.24	-55.11	-26.98
Asset Writedown	-5.32	-	-	-	-
Pretax Income	-163.93	-129.45	-147.24	-55.11	-26.98
Income Tax Expense	-0.6	6	0.9	0.04	-0.23
Earnings From Continuing Operations	-163.34	-135.45	-148.14	-55.15	-26.75
Minority Interest in Earnings	102.15	99.98	40.1	-	-
Net Income	-61.19	-35.47	-108.03	-55.15	-26.75
Preferred Dividends & Other Adjustments	-	-	-93.63	-	-
Net Income to Common	-61.19	-35.47	-14.4	-55.15	-26.75
Shares Outstanding (Basic)	98	62	62	151	105
Shares Outstanding (Diluted)	98	62	62	151	105
Shares Change (YoY)	58.66%	0.28%	-59.17%	43.55%	33.70%
EPS (Basic)	-0.62	-0.57	-0.23	-0.37	-0.25
EPS (Diluted)	-0.62	-0.57	-0.23	-0.37	-0.25
Free Cash Flow	-155.86	-124.27	-78.94	-55.49	-30.64
Free Cash Flow Per Share	-1.59	-2.01	-1.28	-0.37	-0.29
Gross Margin	100.00%	-	-	-	-
Operating Margin	-234673.68%	-	-	-	-
Profit Margin	-80507.89%	-	-	-	-
Free Cash Flow Margin	-205078.95%	-	-	-	-
EBITDA	-172.92	-147.67	-149.97	-53.13	-26.06
D&A For EBITDA	5.43	3.85	3.04	1.98	0.96
EBIT	-178.35	-151.52	-153.01	-55.11	-27.02

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q